OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
With news that Somaxon Pharmaceuticals Inc. (NASDAQ: SOMX) was being targeted for acquisition by Pernix Therapeutics Holdings Inc. (NYSE: PTX) shares of the specialty pharmaceutical company responsible for the insomnia drug Silenor nearly doubled in price on Tuesday, reaching a … Continue reading →
It has been a long time since shareholders of Somaxon Pharmaceuticals, Inc. have had a good night sleep as shares in the company have tumbled from a 52-week high of 10.60 when they received FDA approval for their insomnia drug … Continue reading →
Posted in Articles, NASDAQ
|
Tagged insomnia drug, insomnia market, investors, NASDAQ, nyse, pe, penny stocks, proctor & gamble, silenor, somaxon pharmaceuticals, somx
|
By all accounts Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) should still be enjoying their honeymoon period following last month’s launch of their insomnia drug Silenor. Not only did Somaxon get the green light from the FDA back in March but they … Continue reading →
Posted in Articles, NASDAQ
|
Tagged fda, insomnia, investors, NASDAQ, penny stocks, pharmaceutical, proctor & gamble, silenor, somaxon, somx
|
